Prognostic factors for stage IV gastric cancer

Int Surg. 2013 Apr-Jun;98(2):181-7. doi: 10.9738/INTSURG-D-12-00027.1.
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chemotherapy, Adjuvant
  • Drug Combinations
  • Female
  • Gastrectomy*
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Oxonic Acid / therapeutic use
  • Prognosis
  • Pyridines / therapeutic use
  • Retrospective Studies
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / therapy*
  • Survival Analysis
  • Tegafur / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Pyridines
  • tegafur-gimeracil-oteracil
  • Tegafur
  • Oxonic Acid